Lot# MBC092923-2
CTPharma - Tested Mar 1, 2024
28.13%
Total Δ9-THC
Total CBD
1.99%
Total Terpenes
THC-A converts to THC when heated (decarboxylation). Total Δ9-THC = (Δ9-THC) + (THC-A × 0.877) per NYS regulation.
11 tests reported
1 more detected.
As, Cd, Pb, Hg
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| As, Cd, Pb, Hg | - | Unknown |
Aspergillus (flavus, fumigatus, terreus, niger)
Not Detected
Enteropathogenic E. coli
Not Detected
Listeria Monocytogenes
Not Detected
Salmonella species
Not Detected
Shiga Toxin Producing E. coli
Not Detected
Total Aerobic Microbial Count
ND
Total Yeast & Mold Count
100 cfu/g
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Aspergillus (flavus, fumigatus, terreus, niger) | Not Detected | - | Unknown |
| Enteropathogenic E. coli | Not Detected | - | Unknown |
| Listeria Monocytogenes | Not Detected | - | Unknown |
| Salmonella species | Not Detected | - | Unknown |
| Shiga Toxin Producing E. coli | Not Detected | - | Unknown |
| Total Aerobic Microbial Count | 100,000 | Unknown | |
| Total Yeast & Mold Count | 100 cfu/g | 100,000 cfu/g | Unknown |
Aflatoxins (B1, B2, G1, G2)
ND
Ochratoxin-A
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Aflatoxins (B1, B2, G1, G2) | 20 ppb | Pass | |
| Ochratoxin-A | 20 ppb | Pass |
Per Sample ≥ 0.5g
ND
| Analyte | Result | Limit | Status |
|---|---|---|---|
| Per Sample ≥ 0.5g | - | Unknown |
Community Notes
Sign in to add a note.
No notes yet
Be the first to share your thoughts on this product.
Similar Products
Based on terpene profile similarity
EMERALD KUSH LIVE ROSIN VAPE
CTPharma
8 shared terpenes
Blue G Vape 4880
Theraplant
8 shared terpenes
Return of the Mac 1g Pre Roll (H) 00404
Curaleaf
8 shared terpenes
PURE MICHIGAN LIVE ROSIN VAPE
CTPharma
9 shared terpenes
INTERMEDIATE Rythm 3.5g SF Animal Face (I)
Advanced Grow Labs
8 shared terpenes
Details
- Product Type
- N/A
- Lot/Batch
- MBC092923-2
- Sample ID
- N/A
- Laboratory
- NORTHEAST LABORATORIES
- Lab Permit
- ACTL.0000004
- Analysis Date
- Mar 1, 2024